Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
+1 212 318 2000
Europe, Middle East, & Africa
+44 20 7330 7500
+65 6212 1000
BUENOS AIRES, Argentina
GlaxoSmithKline is appealing a fine in Argentina over its pneumonia vaccine for small children.
An judge says the world's second-largest drugmaker must pay $93,000 for protocol problems involving the recruitment of children under five for clinical trials.
A source in Judge Marcelo Aguinsky's office tells The Associated Press that consent forms were signed by illiterate parents or people who didn't have custody of the children. The source spoke on condition of anonymity because the ruling is being challenged.
Both Argentine health officials and London-based GlaxoSmithKline PLC say no links were found between the vaccine and the deaths of 14 babies who had been given placebos during the study.